Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE−/− Mice

Fig. 8

Safety of HMNVsM−D therapy. A H&E staining of different organs from mice of indicated groups. Scale bar = 500 μm. BC Examination of the ALT and AST in mice treated as indicated. DE. RT‐qPCR analysis of Tnfα, Il1β, Ptges and Ptgs2 mRNA levels in the liver or spleen of mice with indicated treatments. Data are presented as mean ± SEM of three independent experiments. Statistical significance was determined by one-way ANOVA with Tukey’s post hoc test. *P < 0.05, **P < 0.01. ns, no significance

Back to article page